Supplementary_File_1 – Supplemental material for Clinical Utility of HLA-B*58:01 Genotyping to Prevent Allopurinol-Induced SJS/TEN

Lavu, Alekhya; Thiriveedi, Sneha; Thomas, Levin; Khera, Kanav; Saravu, Kavitha; Rao, Mahadev

doi:10.25384/SAGE.12479519.v1

Supplementary_File_1.pdf (223.56 kB)

Supplementary_File_1 – Supplemental material for Clinical Utility of HLA-B58:01* Genotyping to Prevent Allopurinol-Induced SJS/TEN

journal contribution

posted on 2020-06-14, 12:07 authored by Alekhya Lavu, Sneha Thiriveedi, Levin Thomas, Kanav Khera, Kavitha Saravu, Mahadev Rao

Supplemental material, Supplementary_File_1 for Clinical Utility of HLA-B*58:01 Genotyping to Prevent Allopurinol-Induced SJS/TEN by Alekhya Lavu, Sneha Thiriveedi, Levin Thomas, Kanav Khera, Kavitha Saravu and Mahadev Rao in Hospital Pharmacy

History

Usage metrics

Keywords

Adverse drug reactions analgesics Skin medication safety gene therapy

Licence

In Copyright

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC